Cost-of-illness of inflammatory bowel disease patients treated with anti-tumour necrosis factor: A French large single-centre experience

DOI: 10.1177/2050640619853448

Keywords: Anti-tumour necrosis factor therapy, costs, Crohn’s disease, inflammatory bowel disease, pharmacoeconomics, ulcerative colitis

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text